Puma Biotechnology Balance Sheet
NASDAQ: PBYIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Puma Biotechnology financial position
At the end of fiscal 2025, Puma Biotechnology reported total assets of $216.3 million, up 1.4% from a year earlier against total liabilities of $86.0 million. Shareholders' equity stood at $130.3 million, or 60.3% of assets. The company held $29.6 million in cash and equivalents against $22.5 million of debt, a net cash position of $7.1 million.
The current ratio (current assets divided by current liabilities) was 2.00, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.17.
Summary generated from market data by MetaCap's automated system. Methodology
Puma Biotechnology balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 29.64M | 69.22M | 84.58M | 76.20M | 63.13M | 85.29M | 60.04M | 108.42M | 81.70M | 194.49M |
| Short-Term Investments | 67.89M | 31.75M | 11.35M | 4.87M | 18.98M | 8.10M | 51.61M | 57.00M | — | 34.98M |
| Receivables | 53.65M | 32.01M | 47.84M | 40.35M | 32.53M | 25.54M | 28.90M | 20.77M | 9.67M | — |
| Inventory | 5.51M | 8.72M | 7.08M | 4.53M | 7.11M | 3.45M | 3.17M | 2.63M | 2.03M | — |
| Total Current Assets | 162.69M | 147.66M | 156.19M | 134.28M | 140.02M | 146.14M | 166.30M | 203.00M | 106.39M | 236.47M |
| Property, Plant & Equipment | 187.00K | 515.00K | 855.00K | 1.15M | 1.76M | 2.48M | 3.30M | 3.96M | 4.47M | 5.15M |
| Intangible Assets | 41.39M | 51.13M | 60.87M | 70.61M | 66.13M | 74.14M | 40.46M | 44.41M | 48.35M | — |
| Total Assets | 216.30M | 213.33M | 230.53M | 222.06M | 226.59M | 244.22M | 234.91M | 259.12M | 165.53M | 252.79M |
| Accounts Payable | 5.06M | 5.51M | 6.89M | 6.44M | 11.17M | 12.08M | 19.18M | 20.68M | 27.69M | 20.04M |
| Short-Term Debt | 22.52M | 45.33M | 34.00M | 0 | 0 | 14.29M | — | — | — | — |
| Total Current Liabilities | 81.25M | 96.11M | 99.38M | 77.48M | 109.59M | 114.25M | 90.84M | 67.11M | 58.34M | 37.46M |
| Long-Term Debt | 0 | 21.72M | 65.66M | 98.31M | 97.09M | 84.03M | 94.96M | 151.89M | 48.48M | — |
| Total Liabilities | 85.96M | 121.21M | 177.09M | 200.45M | 229.03M | 250.17M | 217.44M | 224.82M | 112.22M | 42.97M |
| Shareholders' Equity | 130.34M | 92.13M | 53.44M | 21.61M | -2.45M | -5.95M | 17.46M | 34.31M | 53.30M | 209.82M |
| Retained Earnings | -1.28B | -1.31B | -1.35B | -1.37B | -1.37B | -1.34B | -1.28B | -1.20B | -1.09B | -796.51M |
| Total Debt | 22.52M | 67.05M | 99.66M | 98.31M | 97.09M | 98.31M | 94.96M | 151.89M | 48.48M | — |
| Net Cash (Debt) | 75.00M | 33.92M | -3.72M | -17.23M | -14.99M | -4.92M | 16.68M | 13.54M | 33.22M | 229.48M |
| Shares Outstanding | 50.41M | 49.11M | 47.65M | 46.35M | 41.18M | 40.09M | 39.20M | 38.33M | 37.59M | 36.83M |
This table shows 10 annual periods of Puma Biotechnology's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PBYI's reporting calendar. What is a balance sheet?